We are live on
!
Find out more
PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.08B
1-Year Est. Return
29.51%
This Fund
S&P 500
This Quarter
Est. Return
-19.83%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$2.79B
AUM Growth
-$1.14B
(-29%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-6.46%
Top 10 Holdings %
Top 10 Hldgs %
13.46%
Holding
340
New
37
Increased
107
Reduced
122
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$30.5M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$18M |
| 3 |
Avantor
AVTR
|
+$16.5M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$14.5M |
| 5 |
Boot Barn
BOOT
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$34.9M |
| 2 |
Teladoc Health
TDOC
|
+$33.4M |
| 3 |
Gartner
IT
|
+$20.8M |
| 4 |
AGCO
AGCO
|
+$20.4M |
| 5 |
G-III Apparel Group
GIII
|
+$20.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.01% |
| 2 | Technology | 23.97% |
| 3 | Financials | 15.39% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
126
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.88B
| $7.83M | 0.28% |
39,983
-23,461
| -37% | -$5.05M |
|
127
Monro
MNRO
$358M
| $7.73M | 0.28% |
176,522
+592
| +0.3% | +$35.9K |
|
|
GTLS
128
DELISTED
Chart Industries
GTLS
| $7.32M | 0.26% |
252,464
+880
| +0.3% | +$47.8K |
|
129
MasTec
MTZ
$23B
| $7.27M | 0.26% |
222,211
-2,569
| -1% | -$131K |
|
130
Orion
OEC
$375M
| $7.26M | 0.26% |
972,861
-11,488
| -1% | -$166K |
|
131
Fox Factory Holding Corp
FOXF
$896M
| $7.17M | 0.26% |
170,661
-185,468
| -52% | -$11.7M |
|
132
Coherus Oncology
CHRS
$190M
| $7.12M | 0.26% |
438,891
-4,971
| -1% | -$91.8K |
|
133
Sprout Social
SPT
$593M
| $6.98M | 0.25% |
437,243
+177,000
| +68% | +$3.23M |
|
|
TXNM
134
TXNM Energy Inc
TXNM
$5.91B
| $6.73M | 0.24% |
177,012
-1,882
| -1% | -$91.2K |
|
135
A.O. Smith
AOS
$8.55B
| $6.71M | 0.24% |
177,575
-238,245
| -57% | -$10.2M |
|
136
Kulicke & Soffa
KLIC
$4.96B
| $6.67M | 0.24% |
319,564
-3,845
| -1% | -$94.3K |
|
137
Evolent Health
EVH
$466M
| $6.54M | 0.23% |
1,204,981
+15,862
| +1% | +$142K |
|
138
Axogen
AXGN
$2.61B
| $6.5M | 0.23% |
625,350
+60,631
| +11% | +$772K |
|
139
Zymeworks
ZYME
$1.73B
| $6.37M | 0.23% |
+179,509
| New | +$7.35M |
|
|
BLUE
140
DELISTED
bluebird bio
BLUE
| $6.1M | 0.22% |
10,249
+30
| +0.3% | +$29.2K |
|
141
Winnebago Industries
WGO
$909M
| $5.85M | 0.21% |
210,298
+29,917
| +17% | +$1.44M |
|
142
Century Communities
CCS
$2.01B
| $5.78M | 0.21% |
398,268
-4,789
| -1% | -$137K |
|
|
143
Boot Barn
BOOT
$4.97B
| $5.76M | 0.21% |
+445,151
| New | +$14.2M |
|
144
Dycom Industries
DY
$12.5B
| $5.69M | 0.2% |
221,918
-6,036
| -3% | -$213K |
|
|
PGTI
145
DELISTED
PGT, Inc.
PGTI
| $5.62M | 0.2% |
669,786
+2,095
| +0.3% | +$29.8K |
|
|
PE
146
DELISTED
PARSLEY ENERGY INC
PE
| $5.58M | 0.2% |
974,251
+9,691
| +1% | +$131K |
|
|
BWIN
147
Baldwin Insurance Group
BWIN
$2.92B
| $5.51M | 0.2% |
522,735
+1,687
| +0.3% | +$25.7K |
|
|
ICPT
148
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.51M | 0.2% |
87,500
+32
| +0% | +$2.88K |
|
149
Prestige Consumer Healthcare
PBH
$2.57B
| $5.48M | 0.2% |
149,345
-34,813
| -19% | -$1.35M |
|
150
Lantheus
LNTH
$6.59B
| $5.42M | 0.19% |
424,955
+209,454
| +97% | +$3.35M |
|
Similar funds
CAM
MRCP
ECP
HCM
TCG
CLG
SAG
PC
Peregrine Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Peregrine Capital Management held 340 positions worth $2.79B, down 29% from $3.93B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Peregrine Capital Management withdrew a net $180M in Q1 2020, closing 41 positions and reducing 122 holdings. Its most notable exit was Caesars Entertainment, an estimated $34.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Peregrine Capital Management opened a new position in Uber worth $25.9M.
- Peregrine Capital Management's largest Q1 2020 buy was Uber: 926,512 shares worth $25.9M.
- Peregrine Capital Management added most to KBR in Q1 2020, an estimated $11M increase.
- Peregrine Capital Management's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $33.4M.
- Peregrine Capital Management fully exited Caesars Entertainment in Q1 2020, selling an estimated $34.9M.
- Peregrine Capital Management's ten largest holdings make up 13% of its $2.79B portfolio in Q1 2020.
- Peregrine Capital Management opened 37 new positions and closed 41 in Q1 2020.
- Peregrine Capital Management's portfolio value fell 29% quarter-over-quarter to $2.79B.
Based on Peregrine Capital Management's 13F filing for Q1 2020, filed 17 Apr 2020.